Story thread · 2 reports / 2 sources

Legend Biotech reports 5-year CARVYKTI data in myeloma patients

investing.com · 8h · first report

How the coverage leans

Across 2 sources · syndicated copies counted once

The coverage

  1. Legend's five-year data suggests Carvykti could be a cure; Addex, Indivior split

    endpts.com · 4h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.